Skip to Main Content

WASHINGTON — Senior administration officials are promising that Friday afternoon, President Trump will roll out “the most comprehensive plan to tackle prescription drug affordability of any president.”

But ahead of his 2 p.m. remarks, the White House is keeping the actual plans under wraps — only hinting at the kinds of new policies that might come out in a “blueprint,” to be released alongside the speech and entitled “American Patients First.” In a late Thursday call with reporters, two senior administration officials largely deflected questions about exactly what’s to come in that blueprint, or in a separate “request for information” — an early regulatory outline of proposals — that will also accompany the remarks.


The only specific detail the administration officials would share: the plan will not include a call for Congress to allow Medicare to negotiate drug prices, a policy long favored by many progressive lawmakers and drug price reform advocates. Such negotiations are currently barred by federal law.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.